ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
OraSure Technologies Inc

OraSure Technologies Inc (OSUR)

4,03
-0,21
(-4,95%)
Geschlossen 11 Juni 10:00PM
4,03
0,00
( 0,00% )
Vor Marktöffnung: 10:02AM

OraSure Technologies Inc (OSUR) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
4,03
( - )
Gebot
2,96
Fragen
4,50
Volumen
-
0,00 Tagesbereich 0,00
2,08 52-Wochen-Bereich 4,33
Marktkapitalisierung
Handelsende
4,03
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 598.937
Ausgegebene Aktien
68.848.553
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-3,86
Gewinn pro Aktie (EPS)
-1,05
Erlöse (LTM)
113,02M
Nettogewinn (LTM)
-75,07M

Über OraSure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV s... OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. The company also provides genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of urine samples; and HEMAcollect protein blood collection device. In addition, it provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; OMNIgene SALIVA DNA and RNA collection devices; and OMNIgene GUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Further, it offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Additionally, it develops a molecular self-test for chlamydia trachomatis and neisseria gonorrhoeae. It sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, and companion animal, markets. The company was founded in 1987 and is headquartered in Bethlehem, Pennsylvania. Mehr anzeigen

Sektor
Healthcare
Branche
Medical Equipment & Supplies
Website
Hauptsitz
Bethlehem, United States
Gegründet
1987
OraSure Technologies Inc is listed in the Healthcare sector of the NASDAQ with ticker OSUR. The last closing price for OraSure Technologies was US$4,03. Over the last year, OraSure Technologies shares have traded in a share price range of US$ 2,08 to US$ 4,33.

OraSure Technologies currently has 68.848.553 shares in issue. The market capitalisation of OraSure Technologies is US$277,46 million. OraSure Technologies has a price to earnings ratio (PE ratio) of -3.86.

OSUR Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.143.598971722373.894.2953.897096704.13158768CS
40.9932.56578947373.044.332.928535833.77756541CS
121.1640.41811846692.874.332.82546090363.38169656CS
261.5159.92063492062.524.332.335851713.04321632CS
521.0334.333333333334.332.086200532.96812711CS
156-1.25-23.67424242425.288.452.087352954.41587641CS
260-5.66-58.41073271419.6913.572.087610405.37202282CS

OSUR - Frequently Asked Questions (FAQ)

What is the current OraSure Technologies Inc share price?
The current share price of OraSure Technologies Inc is US$ 4,03
How many OraSure Technologies Inc shares are in issue?
OraSure Technologies Inc has 68.848.553 shares in issue
What is the market cap of OraSure Technologies Inc?
The market capitalisation of OraSure Technologies Inc is USD 277,46M
What is the 1 year trading range for OraSure Technologies Inc share price?
OraSure Technologies Inc has traded in the range of US$ 2,08 to US$ 4,33 during the past year
What is the PE ratio of OraSure Technologies Inc?
The price to earnings ratio of OraSure Technologies Inc is -3,86
What is the cash to sales ratio of OraSure Technologies Inc?
The cash to sales ratio of OraSure Technologies Inc is 2,46
What is the registered address of OraSure Technologies Inc?
The registered address for OraSure Technologies Inc is 220 East First Street, Bethlehem, Pennsylvania, 18015
What is the OraSure Technologies Inc website address?
The website address for OraSure Technologies Inc is www.orasure.com
Which industry sector does OraSure Technologies Inc operate in?
OraSure Technologies Inc operates in the Medical Equipment & Supplies sector

OSUR Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen